Non-classical HLA-G antigen and its role in the cancer progression (Q36421272)

14 August 2017

1 reference

title

Non-classical HLA-G antigen and its role in the cancer progression (English)

1 reference

14 August 2017

Piyush Tripathi

1

1 reference

PubMed ID

16537188

14 August 2017

Suraksha Agrawal

series ordinal

2

1 reference

14 August 2017

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

24

1 reference

14 August 2017

2

1 reference

14 August 2017

178-186

1 reference

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

14 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

HLA-G in cancer: a way to turn off the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Molecular characterization of defective antigen processing in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Dendritic cells hold promise for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

HLA-G and HLA-E: fundamental and Pathophysiological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Expression and regulation of HLA-G in human glioma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

The expression of human leukocyte antigen-G on trophoblasts abolishes the growth-suppressing effect of interleukin-2 towards them

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

HLA-G protein expression is not induced during malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

HLA-G expression in human melanoma cells: protection from NK cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Exosomes bearing HLA-G are released by melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Polymorphism of HLA-G gene and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Selective expression of HLA-G in malignant and premalignant skin specimens in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

HLA-G inhibits the transendothelial cell migration of human NK cells: a strategy for inhibiting xenograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

HLA-G suppresses proliferation of CD4(+) T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

HLA-G in melanoma: can the current controversies be solved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Cancer epigenetics and methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

HLA-G gene repression is reversed by demethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Epigenomics and epigenetic therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900500524579

10.1080/07357900500524579

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16537188